【4568】第一三共 : Daiichi Sankyo Submits Supplemental New Drug Application in Japan for LIXIANA(R)(Edoxaban Tosilate Hydrate) for New Indications

Daiichi Sankyo Submits Supplemental New Drug Application in Japan for LIXIANA(R)(Edoxaban Tosilate Hydrate) for New Indications

出所:株経通信(株式会社みんかぶ)
PDFをダウンロード